Form4insider filings, from the source

SEC Form 4 · accession 0001562180-18-002520

REGENXBIO Inc. · RGNX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Vittal Vasista
Officer — Chief Financial Officer
Period of report
May 15, 2018
Accepted (ET)
May 16, 2018 · 4:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001590877

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2May 15, 2018S1,100$49.21D151,183D
Common StockF3May 15, 2018S3,945$49.93D147,238D
Common StockF4May 15, 2018S2,455$50.76D144,783D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses